Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Short term Debt (2016 - 2025)

SRx Health Solutions' Short term Debt history spans 12 years, with the latest figure at $500000.0 for Q3 2025.

  • For Q3 2025, Short term Debt fell 85.94% year-over-year to $500000.0; the TTM value through Sep 2025 reached $500000.0, down 85.94%, while the annual FY2025 figure was $500000.0, N/A changed from the prior year.
  • Short term Debt reached $500000.0 in Q3 2025 per SRXH's latest filing, down from $4.1 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $4.1 million in Q2 2025 to a low of $162000.0 in Q4 2023.
  • Average Short term Debt over 5 years is $1.7 million, with a median of $1.2 million recorded in 2025.
  • Peak YoY movement for Short term Debt: tumbled 89.07% in 2021, then skyrocketed 1390.12% in 2024.
  • A 5-year view of Short term Debt shows it stood at $855000.0 in 2021, then surged by 124.8% to $1.9 million in 2022, then tumbled by 91.57% to $162000.0 in 2023, then surged by 1390.12% to $2.4 million in 2024, then plummeted by 79.29% to $500000.0 in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Short term Debt are $500000.0 (Q3 2025), $4.1 million (Q2 2025), and $1.2 million (Q1 2025).